Abbott to Acquire Exact Sciences in $21 Billion Agreement
The deal positions Abbott to enter the US cancer screening and precision oncology diagnostics market with products including Cologuard and Oncotype DX tests.
Read More
Search Results for: colorectal cancer screening
Multi-Cancer Blood Test Could Significantly Reduce Late-Stage Diagnoses
A simulation model shows that annual liquid biopsy screening would increase early-stage cancer detection by up to 30% while cutting stage IV diagnoses by 45%.
Read More
Blood Test Shows Superior Sensitivity for Early-Stage Liver Cancer Detection
Oncoguard Liver test demonstrates seven times greater sensitivity for very early-stage hepatocellular carcinoma compared to ultrasound surveillance.
Read More
Blood Test Shows Promise for Tailoring Colon Cancer Chemotherapy
Circulating tumor DNA testing can identify stage 3 patients who may safely receive reduced treatment intensity, international study finds.
Read More
Multi-Cancer Blood Test Shows Seven-Fold Increase in Detection When Added to Standard Screening
PATHFINDER 2 study results indicate more than half of cancers detected by Galleri test were found in early stages, with three-quarters having no current screening options.
Read More